Emerald Advisers’s Guardant Health GH Stock Holding History

Emerald Advisers’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.6M	Sell	364,022 -477,895	-57%	-$52M	1.29%	22
2026 Q1	$77.8M	Sell	841,917 -19,907	-2%	-$2M	2.46%	2
2025 Q4	$88M	Sell	861,824 -11,379	-1%	-$1.02M	2.71%	1
2025 Q3	$54.6M	Buy	873,203 +173,281	+25%	+$9.43M	1.75%	9
2025 Q2	$36.4M	Buy	699,922 +168,498	+32%	+$7.53M	1.34%	22
2025 Q1	$22.6M	Buy	+531,424	New	+$22.9M	1.02%	36
2019 Q1	–	Sell	-20,000	Closed	-$752K	–	258
2018 Q4	$752K	Buy	+20,000	New	+$737K	0.04%	168

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Emerald Advisers's GH Position: Q2 2026 in Review

Emerald Advisers reduced its Guardant Health (GH) stake by 57% in Q2 2026, selling an estimated $52M and leaving 364,022 shares worth $54.6M. The position accounts for 1.29% of the portfolio, ranked #22.

Emerald Advisers first reported a position in GH in Q4 2018 and has held it in 7 quarters since. The position peaked at $88M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Emerald Advisers held 364,022 shares of Guardant Health worth $54.6M as of Q2 2026.
Emerald Advisers sold 477,895 Guardant Health shares in Q2 2026, an estimated $52M.
Guardant Health made up 1.29% of Emerald Advisers's portfolio in Q2 2026, its #22 holding.
Emerald Advisers first reported a position in Guardant Health in Q4 2018 and has held it in 7 quarters since.
Emerald Advisers's Guardant Health position peaked at $88M in Q4 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.